I believe the junior gold market is poised for a great run and I believe now is the time to get back into your favorite gold plays. In September of 2011 I told my subscribers that the resource market was full of fear and uncertainty. I stopped investing in resource plays and focused exclusively on junior biotech stocks. Since that time the junior resource market has been under heavy pressure whi ...

The biotech bull market is rapidly growing. For the past two years I've been carefully looking out for the signs of the biotech bull. This year the signs are coming by a truckload. Every week there is either an M&A deal or some sort of a big-news event. Here are a few interesting recent tidbits...read more TB ...

Bioasis (BTI.V) is my favorite stock at the moment because it will have a catalyst rich 2012 that may send this stock soaring for a 5 to 10 bagger return potential. I've been raving about Bioasis technology potential for a while now. Over the summer, as Bioasis announced a series of successful milestones with their Transcend, blood brain barrier crossing, technology, many big pharmas have sta ...

Bioasis' Transcend program attracts the first big Pharma. Notice this is more then a collab agreement. This is an option to license the product. Transcend has been independently verified as efficacious in delivering biologics across teh blood brain barrier. This is the holy grail as far as the CNS research is concerned. Bioasis holds the key to delivering innumerable therapies to the brain. This w ...

Good things happen to those who patiently sit in a good investment!Cameco Corp. (CCO-T) is making a $520-million hostile takeover bid for Hathor Exploration Ltd. (HAT-T), sending the junior uranium company’s stock soaring in heavy trading after markets opened Friday.Hathor shares closed Thursday at $2.67 on the Toronto Stock Exchange but gained $1.23 to trade at $3.90 with more than four million s ...